PO.CH01.05 · 化学

新橙皮苷二氢查耳酮:一种新型的天然铁死亡抑制剂

Neohesperidin dihydrochalcone: A novel natural inhibitor of ferroptosis

海报缩略图:新橙皮苷二氢查耳酮:一种新型的天然铁死亡抑制剂
编号 3667 展板 26 时间 4/20 02:00–05:00 区域 Section 38 主讲 Bomi Han, BS
分会场 Natural Products
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Bomi Han, Yi-Xi Gong, Seonghye Son, Eui Man Jeong

Jeju National University, Jeju, Korea, Republic of

摘要 Abstract

中文摘要
铁死亡是一种以铁依赖性脂质过氧化物蓄积为特征的调节性细胞死亡形式,日益被认为是多种人类疾病的关键致病机制。鉴于铁死亡在病理学中的重要意义,迫切需要鉴定出具有抗铁死亡活性的新型化学结构类型。近年来,天然产物作为安全有效的铁死亡调节剂来源受到广泛关注。在本研究中,我们鉴定出新橙皮苷二氢查耳酮(NHDC)——一种源自柑橘类水果的黄酮类甜味剂——是一种强效的铁死亡抑制剂。我们证实,NHDC 能显著恢复经 System Xc− 抑制剂 Erastin 处理的 HT-1080 细胞的细胞活力。在机制上,NHDC 处理能有效减轻脂质活性氧(ROS)的蓄积,并调节铁死亡相关蛋白(包括 SLC3A2、SLC7A11 和 PTGS2)的表达。此外,NHDC 通过逆转 Sulfasalazine(SAS,另一种 System Xc− 抑制剂)诱导的脂质 ROS 水平,对 SAS 诱导的铁死亡也表现出保护作用。有趣的是,NHDC 在其保护机制上具有选择性,其活性与 RSL3 诱导的铁死亡通路有所区别。总之,我们的研究结果表明,NHDC 通过靶向抑制 System Xc− 而发挥有效的抗铁死亡作用。本研究为 NHDC 作为治疗铁死亡相关疾病的天然候选药物的治疗潜力提供了宝贵的见解。
查看英文原文 English abstract
Ferroptosis, a form of regulated cell death characterized by the iron-dependent accumulation of lipid peroxides, is increasingly recognized as a critical pathogenic mechanism in various human diseases. Given the significant implication of ferroptosis in pathology, there is an urgent need to identify novel chemotypes with anti-ferroptotic activity. Recently, natural products have garnered attention as safe and effective sources for ferroptosis regulators. In this study, we identified Neohesperidin dihydrochalcone (NHDC), a flavonoid sweetener derived from citrus fruits, as a potent inhibitor of ferroptosis. We demonstrated that NHDC significantly restored cell viability in HT-1080 cells treated with Erastin, a System Xc− inhibitor. Mechanistically, NHDC treatment effectively mitigated the accumulation of lipid reactive oxygen species (ROS) and modulated the expression of ferroptosis-related proteins, including SLC3A2, SLC7A11, and PTGS2. Furthermore, NHDC exhibited a protective effect against ferroptosis induced by Sulfasalazine (SAS), another System Xc− inhibitor, by reverting SAS-induced lipid ROS levels. Interestingly, NHDC showed selectivity in its protective mechanism, distinguishing its activity from RSL3-induced ferroptosis pathways. Collectively, our findings demonstrate that NHDC acts as an effective anti-ferroptotic agent by targeting System Xc− inhibition. This study provides valuable insights into the therapeutic potential of NHDC as a natural candidate for the treatment of ferroptosis-related diseases.
利益披露 Disclosure
B. Han, None.. Y. Gong, None.. S. Son, None.. E. Jeong, None.

← 返回 AACR 2026 检索